LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 433 PLAZA REAL, BOCA RATON, FL, 33432
Mailing Address 433 PLAZA REAL, BOCA RATON, FL, 33432
Phone 310 203 2902
Fiscal Year End 1231
EIN 202903526
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 20, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 8-K Current report of material events | February 18, 2026 | View on SEC |
| 8-K Current report of material events | December 31, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 19, 2025 | View on SEC |
Annual Reports
10-K March 31, 2026
- Lead drug candidate LB-100 shows promise in treating aggressive cancers like Ovarian Clear Cell Carcinoma.
- Strategic partnerships with groups like the Spanish Sarcoma Group help minimize clinical trial costs.
Material Events
8-K Strategy Change March 10, 2026
Medium Impact
- Lixte and Orbit Capital restructured and clarified their partnership regarding Liora Technologies Europe Ltd., a crucial subsidiary for cancer treatment development.
- Orbit Capital now holds a 20% ownership stake in Liora and 700,000 shares of Lixte's common stock, aligning its interests directly with Lixte's overall success.
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN Pharmaceutical Preparations
BIOHARVEST SCIENCES INC.
BHST Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.